Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 52, 2018 - Issue 4
Journal homepage
143
Views
7
CrossRef citations to date
0
Altmetric
Articles

Blood cholesterol, tumor clinical characteristics and risk of prostate cancer progression after radical prostatectomy

Lauri RantaniemiFaculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland; View further author information
,
Teuvo L. J. TammelaFaculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland; ;Department of Urology, Tampere University Hospital, Tampere, Finland; View further author information
,
Paula KujalaDepartment of Pathology, Fimlab Laboratories, Tampere, FinlandView further author information
&
Teemu J. MurtolaFaculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland; ;Department of Urology, Tampere University Hospital, Tampere, Finland; Correspondence[email protected]
View further author information
Pages 269-276 | Received 22 Dec 2017, Accepted 21 Jun 2018, Published online: 26 Oct 2018

References

  • YuPeng L, YuXue Z, PengFei L, et al. Cholesterol levels in blood and the risk of prostate cancer: a meta-analysis of 14 prospective studies. Cancer Epidemiol Biomarkers Prev. 2015;24:1086–1093.
  • Allott EH, Howard LE, Cooperberg MR, et al. Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database. Cancer Epidemiol Biomarkers Prev. 2014;23:2349–2356.
  • Jung J, Lee C, Lee C, et al. Effects of statin use on the response duration to androgen deprivation therapy in metastatic prostate cancer. Korean J Urol. 2015;56:630–636.
  • Mikkelsen MK, Thomsen FB, Berg KD, et al. Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy. Scand J Urol. 2017;51:464–469.
  • Mucci LA, Stampfer MJ. Mounting evidence for prediagnostic use of statins in reducing risk of lethal prostate cancer. J Clin Oncol. 2014;32:1–2.
  • Murtola TJ, Peltomaa AI, Talala K, et al. Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer. European Urology Focus. 2017;3:212–220.
  • Keskivali T, Kujala P, Visakorpi T, et al. Statin use and risk of disease recurrence and death after radical prostatectomy. Prostate. 2016;76:469–478.
  • Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol. 1994;33:365–369.
  • Fimlab homepage. [http://www.fimlab.fi/sivu.tmpl?sivu_id=222] Accessed at 28 Feb. 2017.
  • Martikainen J, Rajaniemi S. Drug reimbursement systems in EU Member states, Iceland and Norway. Available at: [https://helda.helsinki.fi/bitstream/handle/10138/13932/Drug_reimbursement.pdf?sequence=1] Accessed at 28th. Feb. 2017.
  • Gutt R, Tonlaar N, Kunnavakkam R, et al. Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. J Clin Oncol. 2010;28:2653–2659.
  • Kang M, Jeong CW, Ku JH, et al. Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy. PLoS One. 2015;10:e0122438.
  • Wettstein MS, Saba K, Umbehr MH, et al. Prognostic role of preoperative serum lipid levels in patients undergoing radical prostatectomy for clinically localized prostate cancer. Prostate. 2017;77:549–556.
  • Raval AD, Thakker D, Negi H, et al. Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2016;19:222–162.
  • Scosyrev E, Tobis S, Donsky H, et al. Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies. BJU Int. 2013;111:E71–E77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.